Back to Search Start Over

EPCR expression marks UM171-expanded CD34+ cord blood stem cells.

Authors :
Fares, Iman
Chagraoui, Jalila
Lehnertz, Bernhard
MacRae, Tara
Mayotte, Nadine
Tomellini, Elisa
Aubert, Léo
Roux, Philippe P.
Sauvageau, Guy
Source :
Blood. 6/22/2017, Vol. 129 Issue 25, p3344-3351. 8p.
Publication Year :
2017

Abstract

A small subset of human cord blood CD34+ cells express endothelial protein C receptor (EPCR/CD201/PROCR) when exposed to the hematopoietic stem cell (HSC) self-renewal agonist UM171. In this article, we show that EPCR-positive UM171-treated cells, as opposed to EPCR-negative cells, exhibit robust multilineage repopulation and serial reconstitution ability in immunocompromised mice. In contrast to other stem cell markers, such as CD38, EPCR expression is maintained when cells are introduced in culture, irrespective of UM171 treatment. Although engineered overexpression of EPCR fails to reproduce the effects of UM171 on HSC activity, its expression is required for the repopulating activity of human HSCs. Altogether, our results indicate that EPCR is a reliable and cell culture-compatible marker of UM171-expanded human cord blood HSCs. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00064971
Volume :
129
Issue :
25
Database :
Academic Search Index
Journal :
Blood
Publication Type :
Academic Journal
Accession number :
123744756
Full Text :
https://doi.org/10.1182/blood-2016-11-750729